Topical diclofenac for the treatment of the musculoskeletal diseases
Treatment of diseases of the musculoskeletal system to date remains not only a serious medical, but also socio-economic problem. Chronic diseases of the joints and spine are one of the most common causes of disability in patients. The main clinical manifestations of most diseases of the musculoskele...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2018-07-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/2571 |
| _version_ | 1797842139692924928 |
|---|---|
| author | G. R. Imametdinova E. V. Igolkina |
| author_facet | G. R. Imametdinova E. V. Igolkina |
| author_sort | G. R. Imametdinova |
| collection | DOAJ |
| description | Treatment of diseases of the musculoskeletal system to date remains not only a serious medical, but also socio-economic problem. Chronic diseases of the joints and spine are one of the most common causes of disability in patients. The main clinical manifestations of most diseases of the musculoskeletal system are pain and inflammation, which requires adequate antiinflammatory therapy. The data on various mechanisms of action of non-steroidal anti-inflammatory drug (NSAID) diclofenac (Voltaren), as well as the results of clinical studies and meta-analyses confirming its effectiveness and good tolerability are presented. The data of experimental and clinical studies of the efficacy and safety of local forms of diclofenac-Voltaren Emulgel (diclofenac-diethylamine) –are presented. Provides information about the form of the Voltaren Emulgel 2% for 12 hours. It is shown that a wide range of analgesic and anti-inflammatory effects of diclofenac (Voltaren), and good tolerance can be used as symptomatic therapy in the treatment of diseases of the musculoskeletal system. |
| first_indexed | 2024-04-09T16:42:58Z |
| format | Article |
| id | doaj.art-f714eb3b6bc0441d982ab32863dd539c |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:42:58Z |
| publishDate | 2018-07-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-f714eb3b6bc0441d982ab32863dd539c2023-04-23T06:56:37ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-07-010129810410.21518/2079-701X-2018-12-98-1042531Topical diclofenac for the treatment of the musculoskeletal diseasesG. R. Imametdinova0E. V. Igolkina1Federal budgetary state institution «Scientific research Institute of rheumatology named after V. A. Nasonova», MoscowFederal budgetary state institution «Scientific research Institute of rheumatology named after V. A. Nasonova», MoscowTreatment of diseases of the musculoskeletal system to date remains not only a serious medical, but also socio-economic problem. Chronic diseases of the joints and spine are one of the most common causes of disability in patients. The main clinical manifestations of most diseases of the musculoskeletal system are pain and inflammation, which requires adequate antiinflammatory therapy. The data on various mechanisms of action of non-steroidal anti-inflammatory drug (NSAID) diclofenac (Voltaren), as well as the results of clinical studies and meta-analyses confirming its effectiveness and good tolerability are presented. The data of experimental and clinical studies of the efficacy and safety of local forms of diclofenac-Voltaren Emulgel (diclofenac-diethylamine) –are presented. Provides information about the form of the Voltaren Emulgel 2% for 12 hours. It is shown that a wide range of analgesic and anti-inflammatory effects of diclofenac (Voltaren), and good tolerance can be used as symptomatic therapy in the treatment of diseases of the musculoskeletal system.https://www.med-sovet.pro/jour/article/view/2571non-steroidal anti-inflammatory drugsdiseases of the musculoskeletal systemdiclofenacvoltarenvoltaren emulgel |
| spellingShingle | G. R. Imametdinova E. V. Igolkina Topical diclofenac for the treatment of the musculoskeletal diseases Медицинский совет non-steroidal anti-inflammatory drugs diseases of the musculoskeletal system diclofenac voltaren voltaren emulgel |
| title | Topical diclofenac for the treatment of the musculoskeletal diseases |
| title_full | Topical diclofenac for the treatment of the musculoskeletal diseases |
| title_fullStr | Topical diclofenac for the treatment of the musculoskeletal diseases |
| title_full_unstemmed | Topical diclofenac for the treatment of the musculoskeletal diseases |
| title_short | Topical diclofenac for the treatment of the musculoskeletal diseases |
| title_sort | topical diclofenac for the treatment of the musculoskeletal diseases |
| topic | non-steroidal anti-inflammatory drugs diseases of the musculoskeletal system diclofenac voltaren voltaren emulgel |
| url | https://www.med-sovet.pro/jour/article/view/2571 |
| work_keys_str_mv | AT grimametdinova topicaldiclofenacforthetreatmentofthemusculoskeletaldiseases AT evigolkina topicaldiclofenacforthetreatmentofthemusculoskeletaldiseases |